Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 200 | 1.170 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1221 | 1.040 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 129 | 0.870 |
Why?
|
| Blood Glucose | 2 | 2020 | 112 | 0.860 |
Why?
|
| Brain Mapping | 6 | 2021 | 195 | 0.850 |
Why?
|
| Biomarkers | 3 | 2020 | 689 | 0.730 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.730 |
Why?
|
| Headache | 1 | 2019 | 43 | 0.710 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.680 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 27 | 0.670 |
Why?
|
| Lymphocytes | 1 | 2018 | 110 | 0.650 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.610 |
Why?
|
| Sclerosis | 1 | 2017 | 68 | 0.590 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 46 | 0.580 |
Why?
|
| Temporal Lobe | 1 | 2017 | 105 | 0.570 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 96 | 0.550 |
Why?
|
| Thalamus | 4 | 2021 | 28 | 0.540 |
Why?
|
| Image Enhancement | 2 | 2020 | 57 | 0.530 |
Why?
|
| Adult | 22 | 2021 | 8601 | 0.510 |
Why?
|
| Middle Aged | 22 | 2021 | 9823 | 0.510 |
Why?
|
| Humans | 43 | 2022 | 29337 | 0.500 |
Why?
|
| Female | 27 | 2021 | 16197 | 0.490 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 81 | 0.480 |
Why?
|
| Male | 27 | 2021 | 15621 | 0.460 |
Why?
|
| Brain | 6 | 2021 | 1689 | 0.450 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 81 | 0.420 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 90 | 0.400 |
Why?
|
| Brain Ischemia | 2 | 2021 | 71 | 0.360 |
Why?
|
| Aged | 14 | 2021 | 9448 | 0.350 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.350 |
Why?
|
| Motor Cortex | 1 | 2009 | 17 | 0.340 |
Why?
|
| Young Adult | 6 | 2021 | 1932 | 0.330 |
Why?
|
| Brain Diseases | 1 | 2009 | 82 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 117 | 0.330 |
Why?
|
| Graft Rejection | 2 | 2018 | 76 | 0.310 |
Why?
|
| Contrast Media | 3 | 2020 | 125 | 0.290 |
Why?
|
| Liver Transplantation | 2 | 2018 | 79 | 0.290 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 959 | 0.290 |
Why?
|
| Auditory Cortex | 1 | 2005 | 4 | 0.280 |
Why?
|
| Case-Control Studies | 4 | 2021 | 638 | 0.270 |
Why?
|
| Language | 1 | 2005 | 78 | 0.260 |
Why?
|
| Risk Factors | 7 | 2021 | 2443 | 0.260 |
Why?
|
| Sex Characteristics | 1 | 2005 | 132 | 0.250 |
Why?
|
| Postoperative Complications | 3 | 2020 | 957 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 124 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 30 | 0.230 |
Why?
|
| Turkey | 2 | 2018 | 5 | 0.210 |
Why?
|
| Radiology | 1 | 2021 | 22 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3273 | 0.200 |
Why?
|
| Encephalocele | 1 | 2021 | 26 | 0.200 |
Why?
|
| Patient Care Planning | 1 | 2001 | 56 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 35 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 60 | 0.200 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.200 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 37 | 0.200 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.200 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.190 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 20 | 0.190 |
Why?
|
| Parotid Gland | 1 | 2020 | 15 | 0.190 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 113 | 0.190 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 13 | 0.190 |
Why?
|
| Glioma | 1 | 2021 | 47 | 0.190 |
Why?
|
| Dissection | 1 | 2020 | 27 | 0.190 |
Why?
|
| Nerve Net | 1 | 2021 | 54 | 0.190 |
Why?
|
| Hyperglycemia | 1 | 2020 | 34 | 0.190 |
Why?
|
| Gray Matter | 1 | 2021 | 56 | 0.190 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 7 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2021 | 141 | 0.190 |
Why?
|
| Artifacts | 1 | 2020 | 32 | 0.190 |
Why?
|
| Antiviral Agents | 1 | 2021 | 132 | 0.180 |
Why?
|
| Kidney | 1 | 2001 | 173 | 0.180 |
Why?
|
| Fasting | 1 | 2019 | 13 | 0.180 |
Why?
|
| Hernia | 1 | 2019 | 7 | 0.180 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 103 | 0.180 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 10 | 0.180 |
Why?
|
| Brain Edema | 1 | 2019 | 22 | 0.180 |
Why?
|
| White Matter | 2 | 2019 | 149 | 0.180 |
Why?
|
| Sarcoidosis | 1 | 2019 | 13 | 0.180 |
Why?
|
| Emergencies | 1 | 2019 | 39 | 0.180 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 20 | 0.180 |
Why?
|
| Acute Disease | 2 | 2019 | 226 | 0.180 |
Why?
|
| Movement | 1 | 2020 | 143 | 0.180 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 7 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 195 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2020 | 290 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 24 | 0.170 |
Why?
|
| Stomach | 1 | 2018 | 18 | 0.170 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 24 | 0.170 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 51 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 35 | 0.170 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 29 | 0.170 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 22 | 0.170 |
Why?
|
| Adiposity | 1 | 2019 | 47 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2018 | 7 | 0.170 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 42 | 0.170 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 12 | 0.170 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 21 | 0.160 |
Why?
|
| Weight Gain | 1 | 2019 | 66 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 180 | 0.160 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 44 | 0.160 |
Why?
|
| Adolescent | 4 | 2020 | 2279 | 0.160 |
Why?
|
| Nerve Fibers | 1 | 2018 | 14 | 0.160 |
Why?
|
| Child Development | 1 | 2019 | 71 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 32 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 132 | 0.160 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 184 | 0.160 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 7 | 0.160 |
Why?
|
| Biliary Tract | 1 | 2017 | 2 | 0.160 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.160 |
Why?
|
| Spinal Diseases | 1 | 2019 | 150 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 8 | 0.160 |
Why?
|
| Pregnancy | 1 | 2019 | 403 | 0.150 |
Why?
|
| Cysts | 1 | 2017 | 16 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2018 | 115 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 26 | 0.150 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 34 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 219 | 0.150 |
Why?
|
| Calcinosis | 1 | 2017 | 47 | 0.150 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.150 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.150 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 221 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 770 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 553 | 0.150 |
Why?
|
| Functional Laterality | 1 | 2017 | 91 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 218 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2021 | 1811 | 0.140 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 48 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 349 | 0.130 |
Why?
|
| Child | 3 | 2021 | 1346 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 293 | 0.130 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 23 | 0.130 |
Why?
|
| Corpus Callosum | 2 | 2019 | 15 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4851 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 222 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 516 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 840 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2018 | 1164 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1830 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1616 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 41 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1593 | 0.090 |
Why?
|
| Neuroradiography | 1 | 2009 | 3 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 521 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 389 | 0.090 |
Why?
|
| Pediatrics | 1 | 2009 | 33 | 0.090 |
Why?
|
| Subclavian Artery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 5 | 0.080 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 3 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 227 | 0.080 |
Why?
|
| Hospitalization | 2 | 2021 | 317 | 0.080 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 6 | 0.080 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 9 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2009 | 394 | 0.080 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 8 | 0.080 |
Why?
|
| Graft Survival | 2 | 2018 | 98 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2021 | 679 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 349 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 788 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 428 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2006 | 83 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1442 | 0.070 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 15 | 0.060 |
Why?
|
| Frontal Sinus | 1 | 2003 | 12 | 0.060 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 15 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.060 |
Why?
|
| Astrocytoma | 1 | 2003 | 24 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 43 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2003 | 81 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2019 | 642 | 0.060 |
Why?
|
| Blindness | 1 | 2022 | 14 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3478 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 7 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 5 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 30 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 487 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 20 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2020 | 51 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 18 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 46 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2019 | 31 | 0.050 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 56 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 5 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 121 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 496 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 9 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 11 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 22 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 24 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 33 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 66 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 150 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 138 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 107 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 66 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 59 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 11 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 194 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 135 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 138 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 531 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 604 | 0.040 |
Why?
|
| Length of Stay | 1 | 2018 | 317 | 0.040 |
Why?
|
| Mothers | 1 | 2019 | 178 | 0.040 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.040 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 3 | 0.040 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 74 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 13 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 12 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 21 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 402 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 2 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 402 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 11 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2333 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 11 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 20 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 49 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 212 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 374 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 15 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 3 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 6 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 24 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 40 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 81 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 79 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 101 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 175 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 854 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 33 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 42 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 226 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 625 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 4552 | 0.010 |
Why?
|